GlassScriptPhysician profile
Brooke C Meyer
NPI 1285819375
$1,003.78
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $303 · 2022: $462 · 2023: $58.45 · 2024: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $237.34 | 2021-2022 | |
| Amgen INC. | $175.84 | 2021-2023 | Otezla |
| Sun Pharmaceutical Industries INC. | $154.99 | 2022 | |
| Dermavant Sciences, INC. | $145.37 | 2024 | Vtama |
| Pfizer INC. | $93.38 | 2021-2022 | |
| Sandoz INC. | $37.80 | 2021 | |
| Janssen Biotech, INC. | $37.46 | 2021-2023 | Tremfya |
| Lexicon Pharmaceuticals, INC. | $35.29 | 2024 | |
| Incyte Corporation | $30.69 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.27 | 2022-2023 | Sotyktu |
| Abbvie INC. | $25.35 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.